Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-24-107053
Filing Date
2024-10-08
Accepted
2024-10-08 16:31:43
Documents
7
Effectiveness Date
2024-10-08

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm2425768-1_s3asr.htm S-3ASR 220702
2 EXHIBIT 4.7 tm2425768d2_ex4-7.htm EX-4.7 149941
3 EXHIBIT 5.1 tm2425768d2_ex5-1.htm EX-5.1 10226
4 EXHIBIT 23.1 tm2425768d2_ex23-1.htm EX-23.1 2280
5 EX-FILING FEES tm2425768d2_ex-filingfees.htm EX-FILING FEES 12129
6 GRAPHIC tm2425768d2_ex5-1img001.jpg GRAPHIC 10704
7 GRAPHIC lg_immunomereg-4c.jpg GRAPHIC 17336
  Complete submission text file 0001104659-24-107053.txt   435130
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-282548 | Film No.: 241360663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)